To assess the expressions of CCN2, EMA, K19, and FAP in HCCs in regards to their clinicopathologic significance, we investigated these markers by immunohistochemistry of tissue microarrays from 314 cases of HCC (cohort 1). The gene discussed is MUC1; the disease is hepatocellular carcinoma.